-
Signature
-
/s/ Megan Kendrick
-
Issuer symbol
-
NWPX
-
Transactions as of
-
11 Nov 2025
-
Net transactions value
-
-$470,153
-
Form type
-
4
-
Filing time
-
13 Nov 2025, 18:07:42 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| MONTROSS SCOTT J |
President & CEO |
201 NE PARK PLAZA DRIVE, SUITE 100, VANCOUVER |
/s/ Megan Kendrick |
13 Nov 2025 |
0001228503 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
NWPX |
Common Stock |
Sale |
$57,528 |
-1,000 |
-1.3% |
$57.53 |
75,991 |
11 Nov 2025 |
Direct |
F1, F2 |
| transaction |
NWPX |
Common Stock |
Sale |
$86,014 |
-1,500 |
-2% |
$57.34 |
74,491 |
11 Nov 2025 |
Direct |
F1, F3 |
| transaction |
NWPX |
Common Stock |
Sale |
$143,069 |
-2,500 |
-3.4% |
$57.23 |
71,991 |
11 Nov 2025 |
Direct |
F1, F4 |
| transaction |
NWPX |
Common Stock |
Sale |
$183,542 |
-3,210 |
-4.5% |
$57.18 |
68,781 |
11 Nov 2025 |
Direct |
F1, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| holding |
NWPX |
Restricted Stock Units |
|
|
|
|
|
15,585 |
11 Nov 2025 |
Common Stock |
15,585 |
|
Direct |
F6, F7 |
| holding |
NWPX |
Performance Shares |
|
|
|
|
|
46,752 |
11 Nov 2025 |
Common Stock |
46,752 |
|
Direct |
F8, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: